Astec, a global manufacturer of medical equipment for assisted reproduction, has acquired Life Whisperer, a non-invasive and rapid embryo and egg (oocyte) assessment tool designed to improve pregnancy outcomes for IVF patients.
Read More
The peer-reviewed journal Reproductive BioMedicine Online (RBMO) has published results of a global clinical study showing that Artificial Intelligence (AI) can predict the likelihood of an individual human egg (oocyte) developing into an embryo that’s suitable for use in IVF.
Read More
AI healthcare company Presagen has published a novel Artificial Intelligence (AI) algorithm in the journal Nature Scientific Reports, that can automatically detect errors in data without human oversight. The AI algorithm’s accuracy and efficiency was verified on various types of medical data, including images and record-based data.
Read More
AI fertility product Life Whisperer Genetics is now available to IVF clinics in the United States.
Read More
Presagen’s AI-based fertility product, Life Whisperer, will take the spotlight at the prestigious American Society for Reproductive Medicine (ASRM) 2023 conference in New Orleans this month, featuring in four oral presentations.
Read More
Presagen’s Life Whisperer, an AI product to support IVF treatment, will be featured in three new clinical studies at the premier Asia Pacific fertility conference, ASPIRE 2023 in September 2023.
Read More
AI Healthcare company Presagen will be sponsoring, speaking and exhibiting at the Women’s Health Innovation Summit (WHIS), USA, which will be held in Boston in September.
Read More
Presagen’s CEO Dr Michelle Perugini was featured as an AI expert on Australia’s SBS Insights TV program on Artificial Intelligence, titled “AI – Friend or Foe”.
Read More
AI healthcare company Presagen is the winner of Reproductive Biomedicine Online (RMBO’s) annual Robert G. Edwards Prize Paper Award for the best paper published in 2022.
Read More
AI healthcare company Presagen will be presenting results of three new international clinical studies at the prestigious American Society for Reproductive Medicine (ASRM) Annual Meeting in October 2022, in Anaheim, California.
Read More
AI healthcare company Presagen will be sponsoring and presenting at the world’s first fertility conference focused on Artificial Intelligence, to be held in Dubrovnik, Croatia next week.
Read More
Human Reproduction journal has published the ground-breaking results of an international clinical study, where a novel AI algorithm called Life Whisperer Genetics was developed to assess the genetic integrity of embryos using only images.
Read More
Human Reproduction journal has published the ground-breaking results of an international clinical study, where a novel AI algorithm called Life Whisperer Genetics was developed to assess the genetic integrity of embryos using only images.
Read More
Nature Scientific Reports journal has published results of a new decentralized federated AI learning algorithm that can train AI on data that is distributed globally, without having to move private data to a central location.
Read More
A recent paper in the journal Nature Scientific Reports shows that Artificial Intelligence (AI) can automatically detect errors in poor-quality medical data, even errors that are difficult for medical experts to manually identify.
Read More
FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell culture media and assisted reproductive technologies (ART), today announced that it will become the sole worldwide distributor of Life Whisperer.
Read More
Based on its recent analysis of the global AI-enhanced healthcare market, Frost & Sullivan recognizes Presagen with the 2021 Global Product Leadership Award.
Read More
Life Whisperer, the fertility arm of AI healthcare company Presagen, will invite clinics to participate in its third global IVF clinic collaboration at ESHRE 2021.
Read More
Life Whisperer, the fertility arm of AI healthcare company Presagen, has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF.
Read More
Presagen CEO and co-founder, Dr Michelle Perugini was one of an exceptional group of women recognised for their ongoing achievements in AI at an award ceremony held in Sydney in on Friday, 26 March 2021.
Read More